Based in the United States, Bird Rock Bio is a startup.
Bird Rock Bio is a clinical-stage biopharmaceutical company developing immuno-inflammatory regulators and therapeutic antibodies for fibrotic and metabolic diseases. The company applies a proprietary platform (iCAPS) to discover treatments for indications including diabetic nephropathy and NASH.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.